[Drug therapy for disturbances of smelling].
Disorders of the sense of smell are frequent. This severely can affect the quality of live. Appropriate testing is needed to determine the nature of the patient's complaints. Following the pathogenesis, two main groups of smell disorders are discernable: The conductive-respiratory smell disorders, where the odour can not reach the receptor and the senso-neuronal disorders where perception or transduction is affected. Therefore two different therapeutical approaches are described.
HNO Univ. Klinik, AKH - Wien, Austria. Josef.toth@akh-wien.ac.at
J
J
Toth
A F P
AF
Temmel
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D018849:Controlled Clinical Trials as Topic; D004298:Dopamine / Q000627:therapeutic use; D006801:Humans; D000857:Olfaction Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D011810:Quinoxalines / Q000627:therapeutic use; D012903:Smell / Q000502:physiology; D013806:Theophylline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014801:Vitamin A / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D011810:Quinoxalines; D014665:Vasodilator Agents; D014801:Vitamin A; D014803:Vitamin B Complex; D013806:Theophylline; D015032:Zinc; D004298:Dopamine; C000957:caroverine